🟢 DexCom is trading 7.91% up in after-hours trading as broad U.S. indexes gain

DexCom is trading 7.91% up at $89.60 after closing at $83.03 on September 11, 2026, with broad risk-on sentiment likely supporting the move.

• No new September 11 company-specific earnings release, FDA decision, acquisition, or guidance update was identified.
• The most recent company news was Glenn Boehnlein’s board appointment, effective September 10.
• Major U.S. indexes gained roughly 0.87%-0.98%.